GWILX
Price
$16.19
Change
-$0.32 (-1.94%)
Updated
Feb 21 closing price
Net Assets
22.22M
RMFCX
Price
$57.23
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

GWILX vs RMFCX

Header iconGWILX vs RMFCX Comparison
Open Charts GWILX vs RMFCXBanner chart's image
Glenmede Women in Leadership US Eq
Price$16.19
Change-$0.32 (-1.94%)
VolumeN/A
Net Assets22.22M
American Funds American Mutual R3
Price$57.23
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
GWILX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GWILX vs. RMFCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GWILX is a Hold and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. GWILX (22.2M). RMFCX pays higher dividends than GWILX: RMFCX (1.69) vs GWILX (0.94). GWILX was incepted earlier than RMFCX: GWILX (9 years) vs RMFCX (23 years). GWILX is a more actively managed with annual turnover of: 83.00 vs. RMFCX (25.00). GWILX has a lower initial minimum investment than RMFCX: GWILX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 11.03 vs. GWILX (4.53). RMFCX return over 5 years is better than : 41.75 vs. GWILX (14.17).
GWILXRMFCXGWILX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD5.0624.836105%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets22.2M105B0%
Annual Yield % from dividends0.941.6955%
Returns for 1 year4.5311.0341%
Returns for 3 years10.6219.6954%
Returns for 5 years14.1741.7534%
Returns for 10 yearsN/A64.83-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.810.01
+0.07%
Everi Holdings
YETI36.83-0.08
-0.22%
YETI Holdings
GNFT3.83-0.09
-2.30%
Genfit SA
CTXR1.80-0.05
-2.70%
Citius Pharmaceuticals Inc
AER101.67-4.11
-3.89%
Aercap Holdings NV